Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
Clinical trial NCT02175966 · COMPLETED
Trial details
- NCT number
- NCT02175966
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-28
- Primary completion
- 2015-01-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.